A UMH Science Park project develops technologies to diagnose Peripheral Arterial Disease

   ALICANTE, 19 Dic. (EUROPA PRESS) -

A multidisciplinary team of professors and researchers from the Miguel Hernández University Science Park (PCUMH) of Elche (Alicante) works on the ValorITB research project to develop an efficient technology to diagnose Peripheral Arterial Disease (PAD) "quickly and effectively" in patients with diabetic foot.

This arterial disease has a high prevalence in diabetic people, since between 50 and 60 percent have obstruction in the arteries of the foot. With the aim of promoting the development and commercialization of this technology, the project was one of those selected to participate in the Innopropel UMH program, managed by the PCUMH, as indicated by the academic institution in a statement.

The professor of the Nursing Area and expert in podiatry at the UMH Esther Chicharro has pointed out that, currently, the detection and evaluation of this condition is carried out in consultation through a Doppler ultrasound ultrasound. This non-invasive test uses sound waves to measure blood pressure in the extremities.

"Performing this test can take around 30 or 40 minutes. Thanks to the device that we have developed, in collaboration with the Biomedical Neuroengineering Research group at the UMH, we can perform this same measurement in less time and with the same reliability ", he highlighted.

Likewise, the researcher has highlighted that this technology includes "another added value", since compared to the classic methodology, with which "it is difficult to assess arterial obstruction in people with arterial stiffness and calcification", the device developed in the ValorITB project It does allow blood flow to be measured "efficiently and reliably" in this type of patient.

For his part, the professor and member of the Biomedical Neuroengineering research group at the UMH José María Sabater has emphasized the simplicity of use of the technology, since it can be used without prior training. He has also praised that it is portable, since this allows the patient to take it home to monitor themselves.

Likewise, Juan David Romero, also a researcher in this group, has added that this "innovative" device is currently awaiting the result of the patent and immersed in a clinical validation procedure that allows the certification processes to begin in order to launch it to the market. market.

Innopropel UMH is an initiative promoted by the PCUMH, whose purpose focuses on advancing the degree of maturity of the technologies developed within the UMH and their transfer to the business market, through the provision of funds for training and technological maturation. of the selected projects.